THOMAS STEPHEN BASIL sold 32.8% of their position (100K shares) of CLIMB BIO, INC. on the open market
Open‑market sale worth $529.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/17/2026ACC: 0001193125-26-054568
-100K
Net shares
Net seller
$529.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
100K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−90K
Price / share
$5.23
Trade value
$470.99K
% of position
29.5%
2/12/2026
304.66K→214.66K
Common Stock
Direct
Shares
−10K
Price / share
$5.81
Trade value
$58.14K
% of position
4.7%
2/13/2026
214.66K→204.66K
Total
Net shares
−100K
Net value
-$529.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | S · Sale | −90K | $5.23 | $470.99K | 29.5% | 304.66K | 214.66K |
| Common Stock Direct | 2/13/2026 | S · Sale | −10K | $5.81 | $58.14K | 4.7% | 214.66K | 204.66K |
| Total | −100K | -$529.13K | ||||||
Derivative Transactions0
No derivative transactions reported